You can buy or sell IDRA and other stocks, options, and ETFs commission-free!
Idera Pharmaceuticals, Inc. Common Stock, also called Idera Pharmaceuticals, is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. Read More The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA. The listed name for IDRA is Idera Pharmaceuticals, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 5, After Hours